Authors:
GLASPY JA
SHPALL EJ
LEMAISTRE CF
BRIDDELL RA
MENCHACA DM
TURNER SA
LILL M
CHAP L
JONES R
WIERS MD
SHERIDAN WP
MCNIECE IK
Citation: Ja. Glaspy et al., PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION USING STEM-CELL FACTOR IN COMBINATION WITH FILGRASTIM IN BREAST-CANCER PATIENTS, Blood, 90(8), 1997, pp. 2939-2951
Authors:
BASSER RL
RASKO JEJ
CLARKE K
CEBON J
GREEN MD
GRIGG AP
ZALCBERG J
COHEN B
OBYRNE J
MENCHACA DM
FOX RM
BEGLEY CG
Citation: Rl. Basser et al., RANDOMIZED, BLINDED, PLACEBO-CONTROLLED PHASE-I TRIAL OF PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR WITH FILGRASTIM AFTER DOSE-INTENSIVE CHEMOTHERAPY IN PATIENTS WITH ADVANCED CANCER, Blood, 89(9), 1997, pp. 3118-3128
Authors:
COSTA JJ
DEMETRI GD
HARRIST TJ
DVORAK AM
HAYES DF
MERICA EA
MENCHACA DM
GRINGERI AJ
SCHWARTZ LB
GALLI SJ
Citation: Jj. Costa et al., RECOMBINANT HUMAN STEM-CELL FACTOR (KIT-LIGAND) PROMOTES HUMAN MAST-CELL AND MELANOCYTE HYPERPLASIA AND FUNCTIONAL ACTIVATION IN-VIVO, The Journal of experimental medicine, 183(6), 1996, pp. 2681-2686
Authors:
COSTA JJ
DEMETRI GD
HARRIST TJ
DVORAK AM
HAYES DF
MERICA EA
MENCHACA DM
GRINGERI AJ
GALLI SJ
Citation: Jj. Costa et al., RECOMBINANT HUMAN STEM-CELL FACTOR (RHSCF) INDUCES CUTANEOUS MAST-CELL ACTIVATION AND HYPERPLASIA, AND HYPERPIGMENTATION IN HUMANS IN-VIVO, Journal of allergy and clinical immunology, 93(1), 1994, pp. 225-225